Works by Yoon, Dok Hyun
Results: 141
Limited role of interim PET/CT in patients with diffuse large B-cell lymphoma treated with R-CHOP.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Role of surgical resection in complete responders on FDG-PET after chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
- Published in:
- Journal of Surgical Oncology, 2014, v. 109, n. 5, p. 472, doi. 10.1002/jso.23514
- By:
- Publication type:
- Article
Prevalence, clinical features, and survival outcome trends of 627 patients with primary cutaneous lymphoma over 29 years: a retrospective review from single tertiary center in Korea.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-71210-y
- By:
- Publication type:
- Article
The Prognostic Significance of Vitamin D Deficiency in Korean Patients With Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 3, p. e112, doi. 10.1016/j.clml.2023.12.002
- By:
- Publication type:
- Article
P-118: Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S99, doi. 10.1016/S2152-2650(21)02245-X
- By:
- Publication type:
- Article
ABCL-346: Overall Survival with Tafasitamab + Lenalidomide (LEN) vs Routinely Administered Therapies for ASCT-Ineligible Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Outcomes from the Observational RE-MIND2 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S392, doi. 10.1016/S2152-2650(21)01891-7
- By:
- Publication type:
- Article
Poster: ABCL-346: Overall Survival with Tafasitamab + Lenalidomide (LEN) vs Routinely Administered Therapies for ASCT-Ineligible Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Outcomes from the Observational RE-MIND2 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S239, doi. 10.1016/S2152-2650(21)01499-3
- By:
- Publication type:
- Article
Feasibility of heart transplantation for patients with amyloid cardiomyopathy accompanying extracardiac organ involvement.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e317, doi. 10.1016/j.clml.2019.09.522
- By:
- Publication type:
- Article
Clinicopathologic characteristics and clinical outcome of multiple myeloma with del(17p): A retrospective analysis of single center experience for 12 years.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e60, doi. 10.1016/j.clml.2019.09.093
- By:
- Publication type:
- Article
Efficacy and Survival Outcome Associated with the Use of Novel Agents and Autologous Stem Cell Transplantation in Cases of Immunoglobulin D Multiple Myeloma in Korea.
- Published in:
- Acta Haematologica, 2018, v. 139, n. 3, p. 185, doi. 10.1159/000486664
- By:
- Publication type:
- Article
Comparison of clinical and laboratory characteristics of nonsecretory multiple myeloma and secretory multiple myeloma in a tertiary care hospital.
- Published in:
- International Journal of Laboratory Hematology, 2022, v. 44, n. 3, p. 582, doi. 10.1111/ijlh.13811
- By:
- Publication type:
- Article
Optimization of immune checkpoint inhibitor treatment planning for relapsed or refractory extranodal NK/T cell lymphoma.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 10, p. 4171, doi. 10.1007/s00277-024-05739-3
- By:
- Publication type:
- Article
Immune profiling of patients with extranodal natural killer/T cell lymphoma treated with daratumumab.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 6, p. 1989, doi. 10.1007/s00277-023-05603-w
- By:
- Publication type:
- Article
Correction to: RE‑MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola‑BR), CAR‑T therapies, and lenalidomide/rituximab (R2) based on real‑world data in patients with relapsed/refractory diffuse large B‑cell lymphoma
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
RE-MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) based on real-world data in patients with relapsed/refractory diffuse large B-cell lymphoma
- Published in:
- Annals of Hematology, 2023, v. 102, n. 7, p. 1773, doi. 10.1007/s00277-023-05196-4
- By:
- Publication type:
- Article
Correction to: Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 6, p. 1217, doi. 10.1007/s00277-022-04776-0
- By:
- Publication type:
- Article
Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Long-term follow-up of abbreviated R-CHOP chemoimmunotherapy for completely resected limited-stage diffuse large B cell lymphoma (CISL 12-09).
- Published in:
- Annals of Hematology, 2020, v. 99, n. 12, p. 2831, doi. 10.1007/s00277-020-04284-z
- By:
- Publication type:
- Article
A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study).
- Published in:
- 2020
- By:
- Publication type:
- journal article
A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin's lymphoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Multicenter retrospective analysis of the clinicopathologic features of monomorphic epitheliotropic intestinal T-cell lymphoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Thiotepa, busulfan, and cyclophosphamide or busulfan, cyclophosphamide, and etoposide high-dose chemotherapy followed by autologous stem cell transplantation for consolidation of primary central nervous system lymphoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The cell-of-origin classification of diffuse large B cell lymphoma in a Korean population by the Lymph2Cx assay and its correlation with immunohistochemical algorithms.
- Published in:
- Annals of Hematology, 2018, v. 97, n. 12, p. 2363, doi. 10.1007/s00277-018-3442-2
- By:
- Publication type:
- Article
Treating synchronous bilateral ocular adnexal marginal zone lymphoma: the consortium for improving survival of lymphoma study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The cell-of-origin classification of diffuse large B cell lymphoma in a Korean population by the Lymph2Cx assay and its correlation with immunohistochemical algorithms.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
PD-L1 expression correlates with VEGF and microvessel density in patients with uniformly treated classical Hodgkin lymphoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Interim <sup>18</sup>F-FGD PET/CT may not predict the outcome in primary central nervous system lymphoma patients treated with sequential treatment with methotrexate and cytarabine.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Sexual problems in male vs. female non-Hodgkin lymphoma survivors: prevalence, correlates, and associations with health-related quality of life.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A new extranodal scoring system based on the prognostically relevant extranodal sites in diffuse large B-cell lymphoma, not otherwise specified treated with chemoimmunotherapy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The clinical impact of thalidomide maintenance after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma in real clinical practice of Korea.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Pretreatment whole blood Epstein-Barr virus-DNA is a significant prognostic marker in patients with Hodgkin lymphoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Prognostic factors for re-mobilization using plerixafor and granulocyte colony-stimulating factor (G-CSF) in patients with malignant lymphoma or multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy: the Korean multicenter retrospective study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Changing trend of Epstein-Barr virus association in Hodgkin lymphoma in the Republic of Korea.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 12, p. 1653, doi. 10.1007/s00277-013-1837-7
- By:
- Publication type:
- Article
Point prevalence of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Clinical characteristics and outcomes of patients with chronic disseminated candidiasis who need adjuvant corticosteroid therapy.
- Published in:
- Medical Mycology, 2018, v. 56, n. 6, p. 782, doi. 10.1093/mmy/myx110
- By:
- Publication type:
- Article
Pneumocystis pneumonia versus rituximab-induced interstitial lung disease in lymphoma patients receiving rituximab-containing chemotherapy.
- Published in:
- Medical Mycology, 2017, v. 55, n. 4, p. 349, doi. 10.1093/mmy/myw095
- By:
- Publication type:
- Article
Subtle CD20 positivity in the bone marrow of a patient who has a mucosa-associated lymphoid tissue lymphoma should not be regarded as evidence of involvement in the bone marrow.
- Published in:
- Histopathology, 2013, v. 62, n. 3, p. 397, doi. 10.1111/his.12005
- By:
- Publication type:
- Article
p16 immunohistochemistry alone is a better prognosticator in tonsil cancer than human papillomavirus in situ hybridization with or without p16 immunohistochemistry.
- Published in:
- Acta Oto-Laryngologica, 2013, v. 133, n. 3, p. 297, doi. 10.3109/00016489.2012.741327
- By:
- Publication type:
- Article
Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-020-01020-y
- By:
- Publication type:
- Article
p34<sup>SEI-1</sup> inhibits ROS-induced cell death through suppression of ASK1.
- Published in:
- Cancer Biology & Therapy, 2011, v. 12, n. 5, p. 421, doi. 10.4161/cbt.12.5.15972
- By:
- Publication type:
- Article
CT Demonstration of Local Cytokine-Release Syndrome Involving the Head and Neck Following Chimeric Antigen Receptor T Cell Infusion Therapy.
- Published in:
- Korean Journal of Radiology, 2024, v. 25, n. 4, p. 399, doi. 10.3348/kjr.2023.1100
- By:
- Publication type:
- Article
Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis.
- Published in:
- Cancer Communications, 2021, v. 41, n. 3, p. 275, doi. 10.1002/cac2.12150
- By:
- Publication type:
- Article
Recurrence patterns of mucose-associated lymphoid tissue lymphoma after definitive radiation treatment: A single center experience.
- Published in:
- Hematology, 2016, v. 21, n. 9, p. 542, doi. 10.1080/10245332.2016.1164933
- By:
- Publication type:
- Article
Efficacy and toxicity of the combination chemotherapy of thalidomide, alkylating agent, and steroid for relapsed/refractory myeloma patients: a report from the Korean Multiple Myeloma Working Party (KMMWP) retrospective study.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 1, p. 100, doi. 10.1002/cam4.970
- By:
- Publication type:
- Article
A Randomized Feasibility Study of <sup>18</sup>F-Fluoroestradiol PET to Predict Pathologic Response to Neoadjuvant Therapy in Estrogen Receptor-Rich Postmenopausal Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 4, p. 563, doi. 10.2967/jnumed.116.178368
- By:
- Publication type:
- Article
Clinical Characteristics and Prognostic Factors of Adenoid Cystic Carcinoma of the Head and Neck.
- Published in:
- Laryngoscope, 2013, v. 123, n. 6, p. 1430, doi. 10.1002/lary.23976
- By:
- Publication type:
- Article
Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article